Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SPERO HEALTH OF INDIANA, LLC

NPI: 1962900183 · INDIANAPOLIS, IN 46227 · Substance Use Disorder Rehabilitation Clinic/Center · NPI assigned 01/23/2018

$8.56M
Total Medicaid Paid
151,132
Total Claims
89,474
Beneficiaries
17
Codes Billed
2019-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialADAMS, RICHARD (CFO)
NPI Enumeration Date01/23/2018

Related Entities

Other providers sharing the same authorized official: ADAMS, RICHARD

ProviderCityStateTotal Paid
SPERO HEALTH OF KENTUCKY, LLC DANVILLE KY $154.25M
SPERO HEALTH OF OHIO, LLC ZANESVILLE OH $46.00M
SPERO HEALTH OF VIRGINIA, LLC MARTINSVILLE VA $9.75M
TRI-STATE ORTHOPAEDIC SURGEONS, INC. EVANSVILLE IN $1.09M
BUTLER EMERGENCY PHYSICIANS ASSOCIATES BUTLER PA $398K
SPERO HEALTH OF WEST VIRGINIA, LLC CLARKSBURG WV $391K
RICHARD M ADAMS DPM PA GRANBURY TX $4K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 10,722 $421K
2020 22,019 $966K
2021 27,177 $1.57M
2022 33,793 $2.23M
2023 37,533 $2.14M
2024 19,888 $1.23M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 18,554 10,503 $1.55M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 34,485 17,585 $1.49M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 12,110 7,764 $1.46M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 22,620 14,100 $1.40M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 13,272 7,934 $910K
90832 Psychotherapy, 30 minutes with patient 16,766 12,090 $709K
90853 Group psychotherapy (other than of a multiple-family group) 23,523 12,846 $390K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 2,422 1,537 $203K
90791 Psychiatric diagnostic evaluation 1,600 1,418 $155K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3,109 1,749 $119K
99215 Prolong outpt/office vis 509 363 $68K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 242 228 $30K
90837 Psychotherapy, 53 minutes with patient 254 229 $23K
99205 Prolong outpt/office vis 156 139 $23K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 292 243 $20K
H0038 Self-help/peer services, per 15 minutes 1,135 683 $14K
90834 Psychotherapy, 45 minutes with patient 83 63 $5K